Rome hosted the 21st Congress of the European Association of Neuro-Oncology (EANO) from 24 to 27 September, bringing together experts in the research, diagnosis and treatment of nervous system tumours at one of Europe's most important neuro-oncology meetings. Researchers from all three NICR nodes were also among the active participants.
This year's congress opened with a multidisciplinary educational day, followed by the main scientific programme. The programme presented the latest clinical trial results, advances in basic research and precision diagnostics, as well as new approaches to the local and systemic treatment of nervous system tumours. Topics included tumour cell biology and the tumour microenvironment, immunotherapy, brain tumours in children and adults, brain metastases and patients' quality of life.
One of EANO's defining features is its broad multidisciplinary community, bringing together specialists in neurosurgery, neurology, neuropathology, neuroradiology, radiation and clinical oncology, as well as basic and clinical research. In addition to physicians and scientists, the association includes other healthcare professionals and patient organisations. Bringing together different professions and perspectives is essential for the further development of neuro-oncology. Czech neuro-oncology is becoming an increasingly visible part of EANO, both through its scientific achievements and through active involvement in the association's governing bodies. This is also reflected in the fact that Aleksi Šedo, Director of NICR, will serve on EANO's Executive Board for another term.
“EANO has become a remarkably important and productive community for European neuro-oncology and, perhaps just as importantly, it is a community of people I genuinely like working with. I am very happy to have joined its Executive Board and look forward to contributing to what comes next. A privilege, certainly – but above all a responsibility and some work to do,” says Aleksi Šedo.
EANO also brings together national neuro-oncology societies, providing a platform for mutual cooperation. Czech neuro-oncology holds a strong position within the association, and experience gained through EANO may also serve as inspiration for the future establishment of an independent professional neuro-oncology society in the Czech Republic.
For more information about the congress, visit the EANO 2026 website.
